Early detection in lung cancer. Case finding and screening

Area of Science:

• Oncology
• Public Health
• Preventive Medicine

Background:

• Lung cancer primary prevention, specifically smoking cessation, is widely accepted as the most effective strategy.
• Despite declining smoking rates, new teenage smokers emerge daily, necessitating ongoing prevention efforts.
• The debate on early detection methods like chest X-ray (CXR) or sputum for lung cancer persists.

Purpose of the Study:

• To evaluate the effectiveness of primary prevention strategies for lung cancer.
• To discuss the current status and future potential of early detection methods for lung cancer.
• To differentiate between screening and case finding in the context of lung cancer management.

Main Methods:

• Review of existing evidence on primary prevention and smoking cessation interventions.
• Analysis of the proposed Monosyllabic Verbal Response Office Cancer Screening Test (MVROCST).
• Discussion of the ongoing Prostate, Lung, Colon and Ovary Cancer Screening Trial (PLCO) lung cancer arm evaluating yearly CXR.

Main Results:

• Physician advice to quit smoking is effective in reducing lung cancer risk, with benefits seen as early as 5 years post-cessation.
• Current early detection tools for lung cancer lack sufficient evidence of effectiveness and practicality.
• Screening the general population for lung cancer using tests like CXR is not currently recommended based on available data.

Conclusions:

• Primary prevention, particularly smoking cessation, should be central to lung cancer control efforts.
• Early detection of lung cancer remains conceptually sound but practically challenging; further research into biomarkers is promising.
• Screening is not recommended for lung cancer; however, case finding in patients seeking care may offer different opportunities for intervention.